FI10194U1 - Compositions containing cetilate - Google Patents

Compositions containing cetilate

Info

Publication number
FI10194U1
FI10194U1 FIU20124262U FIU20124262U FI10194U1 FI 10194 U1 FI10194 U1 FI 10194U1 FI U20124262 U FIU20124262 U FI U20124262U FI U20124262 U FIU20124262 U FI U20124262U FI 10194 U1 FI10194 U1 FI 10194U1
Authority
FI
Finland
Prior art keywords
cetilate
compositions containing
compositions
formulations
relates
Prior art date
Application number
FIU20124262U
Other languages
Finnish (fi)
Swedish (sv)
Inventor
John Robert Bloor
Christopher Robert Dunk
Richard Michael John Palmer
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122213.0A external-priority patent/GB201122213D0/en
Priority claimed from GBGB1203082.1A external-priority patent/GB201203082D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Application granted granted Critical
Publication of FI10194U1 publication Critical patent/FI10194U1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Logic Circuits (AREA)
  • Manipulation Of Pulses (AREA)

Abstract

Abstract The present invention relates to compositions comprising cetilistat, including its salts, esters, amides, solvates, polymorphs, and mixtures thereof The invention also relates to 5 formulations comprising such compositions, to processes for preparation of the compositions and formulations, and to their methods of use for weight management, including weight loss.
FIU20124262U 2011-12-23 2012-12-20 Compositions containing cetilate FI10194U1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1122213.0A GB201122213D0 (en) 2011-12-23 2011-12-23 Compositions
GBGB1203082.1A GB201203082D0 (en) 2012-02-22 2012-02-22 Compositions

Publications (1)

Publication Number Publication Date
FI10194U1 true FI10194U1 (en) 2013-08-20

Family

ID=47560448

Family Applications (1)

Application Number Title Priority Date Filing Date
FIU20124262U FI10194U1 (en) 2011-12-23 2012-12-20 Compositions containing cetilate

Country Status (8)

Country Link
AU (1) AU2012101841A4 (en)
DK (1) DK201200198Y4 (en)
ES (1) ES2417408B1 (en)
FI (1) FI10194U1 (en)
FR (1) FR2984745B3 (en)
IE (1) IES20120556A2 (en)
IT (1) ITTO20121118A1 (en)
NL (1) NL2009995C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AR022204A1 (en) * 1999-01-08 2002-09-04 Norgine Bv COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND EDIBLE PRODUCT THAT UNDERSTANDS IT.
PT1897558E (en) * 2005-06-09 2013-11-06 Norgine Bv Solid preparation of 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one
JP2010254623A (en) * 2009-04-24 2010-11-11 Takeda Chem Ind Ltd Crystal of benzoxazinone compound

Also Published As

Publication number Publication date
ES2417408A2 (en) 2013-08-07
FR2984745A3 (en) 2013-06-28
NL2009995C2 (en) 2013-09-18
IES86183B2 (en) 2013-05-08
IES20120556A2 (en) 2013-05-08
FR2984745B3 (en) 2017-12-22
ES2417408B1 (en) 2014-11-26
DK201200198U1 (en) 2013-04-12
AU2012101841A4 (en) 2013-01-17
DK201200198Y4 (en) 2018-09-17
NL2009995A (en) 2013-06-26
ITTO20121118A1 (en) 2013-06-24
ES2417408R1 (en) 2013-10-15

Similar Documents

Publication Publication Date Title
CY1119762T1 (en) C-17-Hetero-aryl derivatives of oleic acid and methods for their use
NZ706739A (en) Substituted benzene compounds
EA201500652A1 (en) DIFTLOROMETILNIKOTINOVY INDANILKARBOKSAMIDY
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
EA201490357A1 (en) INTRODUCTION
IN2014MN02106A (en)
IN2014MN02598A (en)
PH12015501609A1 (en) Phenicol antibacterials
EA201490471A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS
EA201390163A1 (en) HETEROBICYCLIC DERIVATIVES AS HCV INHIBITORS
CR20140135A (en) NEW DERIVATIVES OF ARIL-QUINOLINA
EA201490037A1 (en) ANTAGONISTS TRPV4
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
IN2014CN01216A (en)
CL2013003056A1 (en) Compounds derived from (phenyl or pyridin) -ethynyl- (pyridin or pyrimidin) substituted; pharmaceutical composition comprising them; process of preparing this; and its use in the treatment of schizophrenia or cognitive diseases.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
UY33528A (en) DERIVATIVES OF OXADIAZOLS AND PIRIDAZINES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
IN2015DN02109A (en)
MX2015004312A (en) Flavor and fragrance formulation (i).
MX2013009386A (en) New azaspirodecanone compounds.
IN2014CN01217A (en)
EA201390488A1 (en) NEW GPR 119 AGONISTS
EA201590846A1 (en) CLASSY
MX2015005312A (en) 1 h-indole-3-carboxamide derivatives and use thereof as p2y12 antagonists.
MY166057A (en) Carbocyclic nucleosides and their pharmaceutical use and compositions

Legal Events

Date Code Title Description
FGU Utility model registered

Ref document number: 10194

Country of ref document: FI

Kind code of ref document: U1

MMU Utility model lapsed